Venous thrombosis after myocardial infarction

The role of T-helper cells in atherosclerosis.

Cardiovascular & hematological agents in medicinal chemistry·2010

Original Article: Insensitivity of Platelet Aggregation to Inhibition by Prostaglandin I(2) (PGI(2)) and Prostaglandin E(1) (PGE(1)), and Reduced Platelet c-AMP Accumulation in Response to PGE(1) in Insulin-dependent Diabetic Patients.

Platelets·2010

Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study.

Journal of thrombosis and haemostasis : JTH·2010

The role of integrin-mediated cell adhesion in atherosclerosis: pathophysiology and clinical opportunities.

Current pharmaceutical design·2008

Major joint replacement. A model for antithrombotic drug development: from proof-of-concept to clinical use.

International angiology : a journal of the International Union of Angiology·2008

Management of venous thromboembolism.

The Journal of the Association of Physicians of India·2007

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Pre-Transplant Left Atrial Volume Index and One-Year Morbidity After Kidney Transplantation.

Clinical transplantation·2026

Viral coinfections and checkpoint-marker expression in HIV: An exploratory HCV-Related CD4⁺ T-Cell PD-L1 pattern.

Immunologic research·2026

Concordance of genetic determinants of acute coronary artery disease between European and Chinese populations.

GigaScience·2026

Management of Recurrent C3 Glomerulopathy After Kidney Transplantation.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026

Sex Based Differences in Association Between Plaque Burden and Ischemia -- a CREDENCE Trial Substudy.

European heart journal. Cardiovascular Imaging·2026

RUNX1-driven endothelial-to-mesenchymal transition contributes to remodelling in LMNA cardiomyopathy.

European heart journal·2026

Related Experiment Videos

Venous thrombosis after myocardial infarction

Related Concept Videos

The role of T-helper cells in atherosclerosis.

Original Article: Insensitivity of Platelet Aggregation to Inhibition by Prostaglandin I(2) (PGI(2)) and Prostaglandin E(1) (PGE(1)), and Reduced Platelet c-AMP Accumulation in Response to PGE(1) in Insulin-dependent Diabetic Patients.

Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study.

The role of integrin-mediated cell adhesion in atherosclerosis: pathophysiology and clinical opportunities.

Major joint replacement. A model for antithrombotic drug development: from proof-of-concept to clinical use.

Management of venous thromboembolism.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Pre-Transplant Left Atrial Volume Index and One-Year Morbidity After Kidney Transplantation.

Viral coinfections and checkpoint-marker expression in HIV: An exploratory HCV-Related CD4⁺ T-Cell PD-L1 pattern.

Concordance of genetic determinants of acute coronary artery disease between European and Chinese populations.

Management of Recurrent C3 Glomerulopathy After Kidney Transplantation.

Sex Based Differences in Association Between Plaque Burden and Ischemia -- a CREDENCE Trial Substudy.

RUNX1-driven endothelial-to-mesenchymal transition contributes to remodelling in LMNA cardiomyopathy.

Related Experiment Videos

Venous thrombosis after myocardial infarction

Related Concept Videos

Related Articles